Pinter, M <br/><br/>
Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  Oct 2011 
 - 949-59 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1365-2036 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2036.2011.04823.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Benzenesulfonates--therapeutic use<br/>Carcinoma, Hepatocellular--drug therapy<br/>Female<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Magnetic Resonance Imaging<br/>Male<br/>Middle Aged<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds<br/>Prognosis<br/>Pyridines--therapeutic use<br/>Retrospective Studies<br/>Severity of Illness Index<br/>Sorafenib<br/>Statistics as Topic<br/>Survival Rate<br/>Tomography, X-Ray Computed